Radiopharm Theranostics Limited

RADX · NASDAQ
Analyze with AI
6/30/2025
6/30/2024
6/30/2023
6/30/2022
Operating Activities
Net Income$0-$0-$0-$0
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$0$0$0$0
Other Non-Cash-$0$0$0$0
Operating Cash Flow-$0-$0-$0-$0
Investing Activities
PP&E Inv.$0$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0-$0-$0-$0
Investing Cash Flow$0-$0-$0-$0
Financing Activities
Debt Repay.-$0$0$0-$0
Stock Issued$0$0$0$0
Stock Repurch.$0-$0-$0-$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0-$0$0$0
Financing Cash Flow$0$0$0$0
Forex Effect-$0-$0$0$0
Net Chg. in Cash$0$0-$0$0
Supplemental Information
Beg. Cash$0$0$0$0
End Cash$0$0$0$0
Free Cash Flow-$0-$0-$0-$0
Radiopharm Theranostics Limited (RADX) Financial Statements & Key Stats | AlphaPilot